Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Pharmacies to get more power to give Drugs without Prescriptions

      Pharmacies to get more power to give Drugs without Prescriptions

      Ruby Khatun Khatun20 Sept 2017 9:02 PM IST
      New Delhi: The Central Drugs Standard Control Organization (CDSCO) is planning to introduce provisions in the Drugs and Cosmetics rules to allow...
      Cadila in pact with Russian firm for chickenpox vaccine

      Cadila in pact with Russian firm for chickenpox vaccine

      Ruby Khatun Khatun20 Sept 2017 10:47 AM IST
      New Delhi: Drug firm Cadila Healthcare on Tuesday said it has signed a technology agreement with Russian firm Pharm Aid Ltd for production of...
      Sachin, Sindhu back out of proposed investment in Health

      Sachin, Sindhu back out of proposed investment in Health

      Ruby Khatun Khatun20 Sept 2017 10:18 AM IST
      New Delhi: Legendary cricketer Sachin Tendulkar and ace shuttler PV Sindhu have called off their talks for investing in Hyderabad-based CallHealth...
      Glenmark gets USFDA nod for generic skin ointment

      Glenmark gets USFDA nod for generic skin ointment

      Ruby Khatun Khatun20 Sept 2017 10:17 AM IST
      New Delhi: Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market Desonide Ointment, used to treat...
      Bayer to end non-US sales of Essure, a contested sterilisation implant

      Bayer to end non-US sales of Essure, a contested sterilisation implant

      Ruby Khatun Khatun20 Sept 2017 9:47 AM IST
      Paris: The pharmaceutical giant Bayer announced on Tuesday that it would end non-US sales of Essure, a sterilisation implant that in news reports has...
      Biosimilar cancer drug threat closing in for Roche

      Biosimilar cancer drug threat closing in for Roche

      Ruby Khatun Khatun20 Sept 2017 9:28 AM IST
      LONDON: The long-heralded threat of cut-price competition to its top-selling biological cancer medicines is finally becoming a reality for Roche, the...
      Temasek buys Rs 1,000 crore stake in Manipal Hospitals

      Temasek buys Rs 1,000 crore stake in Manipal Hospitals

      Ruby Khatun Khatun19 Sept 2017 6:11 PM IST
      Mumbai: Temasek Holding, a Singapore based company has agreed to acquire a stake in Manipal hospitals worth Rs 1,000 crore. A transaction has been...
      Fosun Pharma to buy 74 percent stake in Gland Pharma for 1.1 billion dollar

      Fosun Pharma to buy 74 percent stake in Gland Pharma for 1.1 billion dollar

      Ruby Khatun Khatun19 Sept 2017 10:47 AM IST
      BEIJING/MUMBAI: Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India's Gland Pharma to 74 percent for $1.1...
      Lupin appoints Jim Loerop as Chief Corporate Development Officer

      Lupin appoints Jim Loerop as Chief Corporate Development Officer

      Ruby Khatun Khatun19 Sept 2017 10:29 AM IST
      Mumbai: Pharma Major Lupin announced the appointment of Jim Loerop as Chief Corporate Development Officer. Jim will lead Lupin's overall corporate...
      Glenmark looks to file up to 25 product applications annually

      Glenmark looks to file up to 25 product applications annually

      Ruby Khatun Khatun19 Sept 2017 10:19 AM IST
      New Delhi: Glenmark Pharmaceuticals plans to file close to 25 product applications annually over the next five years, the company's chairman has...
      USFDA approves GSK three-in-one drug inhaler for COPD

      USFDA approves GSK three-in-one drug inhaler for COPD

      Ruby Khatun Khatun19 Sept 2017 9:57 AM IST
      GlaxoSmithKline Plc (GSK) and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for the...
      FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy.

      FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy.

      Ruby Khatun Khatun19 Sept 2017 9:24 AM IST
      ATLANTA and BRUSSELS: UCB announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok